Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Ronzitti

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2017
Combination Therapy Is the New Gene Therapy?Giuseppe Ronzitti, Federico Mingozzi
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2023
Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectorsAntoine Gardin, Giuseppe Ronzitti
Toxicology|December 25, 2007
Yessotoxin induces the accumulation of altered E-cadherin dimers that are not part of adhesive structures in intact cellsGiuseppe Ronzitti, Gian Paolo Rossini
Molecular Therapy. Methods & Clinical Development|January 13, 2018
Emerging Issues in AAV-Mediated <i>In Vivo</i> Gene TherapyPasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi
Frontiers in Immunology|May 5, 2020
Human Immune Responses to Adeno-Associated Virus (AAV) VectorsGiuseppe Ronzitti, David-Alexandre Gross, Federico Mingozzi
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2026
Promises of co-stimulatory inhibition for durable and repeatable AAV gene therapyKlaudia Kuranda, David Alexandre Gross, Giuseppe Ronzitti
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2025
Harnessing B19-directed CAR T cells for AAV vector administration in seropositive patients: The importance of the nicheHanadi Saliba, David Alexandre Gross, Giuseppe Ronzitti
Annals of Translational Medicine|August 9, 2019
Progress and challenges of gene therapy for Pompe diseaseGiuseppe Ronzitti, Fanny Collaud, Pascal Laforet, et al.
Channels (Austin, Tex.)|June 24, 2015
Raft-partitioning of calcium channels regulates their functionGiuseppe Ronzitti, Giovanna Bucci, Gary Stephens, et al.
Expert Opinion on Biological Therapy|December 29, 2022
What's next in gene therapy for Crigler-Najjar syndrome?Sem J Aronson, Giuseppe Ronzitti, Piter J Bosma
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2017
Combination Therapy Is the New Gene Therapy?Giuseppe Ronzitti, Federico Mingozzi
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2023
Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectorsAntoine Gardin, Giuseppe Ronzitti
Toxicology|December 25, 2007
Yessotoxin induces the accumulation of altered E-cadherin dimers that are not part of adhesive structures in intact cellsGiuseppe Ronzitti, Gian Paolo Rossini
Molecular Therapy. Methods & Clinical Development|January 13, 2018
Emerging Issues in AAV-Mediated <i>In Vivo</i> Gene TherapyPasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi
Frontiers in Immunology|May 5, 2020
Human Immune Responses to Adeno-Associated Virus (AAV) VectorsGiuseppe Ronzitti, David-Alexandre Gross, Federico Mingozzi
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2026
Promises of co-stimulatory inhibition for durable and repeatable AAV gene therapyKlaudia Kuranda, David Alexandre Gross, Giuseppe Ronzitti
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2025
Harnessing B19-directed CAR T cells for AAV vector administration in seropositive patients: The importance of the nicheHanadi Saliba, David Alexandre Gross, Giuseppe Ronzitti
Annals of Translational Medicine|August 9, 2019
Progress and challenges of gene therapy for Pompe diseaseGiuseppe Ronzitti, Fanny Collaud, Pascal Laforet, et al.
Channels (Austin, Tex.)|June 24, 2015
Raft-partitioning of calcium channels regulates their functionGiuseppe Ronzitti, Giovanna Bucci, Gary Stephens, et al.
Expert Opinion on Biological Therapy|December 29, 2022
What's next in gene therapy for Crigler-Najjar syndrome?Sem J Aronson, Giuseppe Ronzitti, Piter J Bosma
Pageof 8